Home Cart 0 Sign in  
X

[ CAS No. 16865-11-5 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 16865-11-5
Chemical Structure| 16865-11-5
Chemical Structure| 16865-11-5
Structure of 16865-11-5 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 16865-11-5 ]

Related Doc. of [ 16865-11-5 ]

Alternatived Products of [ 16865-11-5 ]

Product Details of [ 16865-11-5 ]

CAS No. :16865-11-5 MDL No. :MFCD09835289
Formula : C7H3Cl3N2 Boiling Point : -
Linear Structure Formula :- InChI Key :SUQYOUJCBGMSLV-UHFFFAOYSA-N
M.W : 221.47 Pubchem ID :286009
Synonyms :

Calculated chemistry of [ 16865-11-5 ]

Physicochemical Properties

Num. heavy atoms : 12
Num. arom. heavy atoms : 9
Fraction Csp3 : 0.0
Num. rotatable bonds : 0
Num. H-bond acceptors : 1.0
Num. H-bond donors : 1.0
Molar Refractivity : 51.12
TPSA : 28.68 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.02 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.71
Log Po/w (XLOGP3) : 3.7
Log Po/w (WLOGP) : 3.52
Log Po/w (MLOGP) : 2.74
Log Po/w (SILICOS-IT) : 3.93
Consensus Log Po/w : 3.12

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -4.1
Solubility : 0.0176 mg/ml ; 0.0000796 mol/l
Class : Moderately soluble
Log S (Ali) : -3.99
Solubility : 0.0225 mg/ml ; 0.000102 mol/l
Class : Soluble
Log S (SILICOS-IT) : -4.77
Solubility : 0.0038 mg/ml ; 0.0000171 mol/l
Class : Moderately soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 2.0
Synthetic accessibility : 1.53

Safety of [ 16865-11-5 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H332-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 16865-11-5 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 16865-11-5 ]
  • Downstream synthetic route of [ 16865-11-5 ]

[ 16865-11-5 ] Synthesis Path-Upstream   1~7

  • 1
  • [ 2033-29-6 ]
  • [ 16865-11-5 ]
YieldReaction ConditionsOperation in experiment
90%
Stage #1: for 3 h; Reflux
Stage #2: With sodium hydroxide In water at 20℃;
Thoroughly dried 5,6-dichloro- 1 ,3-dihydro-benzoimidazol-2-one (28.4 g, 0.14 mol) was suspended in POCI3 (75 ml_). The reaction solution was heated to reflux temperature for 3 hours and cooled to room temperature. The solution was poured into crushed ice/water (1.5 L) slowly with sufficient stirring. The solution was neutralized to pH = 7.0 with NaOH. The precipitated solid was collected by filtration, washed with water, and dried to afford the title compound (27.9 g, 90percent). The crude product was used in the following reaction without further purification.
71% at 120℃; for 2 h; a screw-cap pressure tube (b) Preparation of the intermediary compound 2,5,6-trichloro-l -benzo[d]imidazole:To 5,6-dichloro-lH-benzo[d]imidazol-2(3H)-one (1.0 g, 4.5 mmol) was added phosphoryl trichloride (4 mL) and the reaction mixture was heated in a screw-cap pressure tube at 12O0C for 2 hours. The reaction mixture was concentrated in vacuo, the residue was diluted with water (30 mL) and the resulting off-white solid was filtered off. The precipitate was washed with water (3x20 mL) and dried under high vacuum to afford 0.77 g (71 percent yield) of 2,5,6-trichloro-lH- benzo[d]imidazole.
71% at 120℃; for 2 h; To 5,6-dichloro-lH-benzo[d]imidazol-2(3H)-one (1.0 g, 4.5 mmol) was added phosphoryl trichloride (4 mL) and the reaction mixture was heated in a screw-cap pressure tube at 120°C for 2 hours. The reaction mixture was concentrated in vacuo, the residue was diluted with water (30 mL) and the resulting off-white solid was filtered off. The precipitate was washed with water (3 x20 mL) and dried under high vacuum to afford 0.77 g (71 percent yield) of 2,5,6-trichloro-lH- benzo[d]imidazole.
Reference: [1] Patent: WO2009/134750, 2009, A1, . Location in patent: Page/Page column 60
[2] Journal of Medicinal Chemistry, 2016, vol. 59, # 15, p. 7188 - 7211
[3] Patent: WO2011/23812, 2011, A1, . Location in patent: Page/Page column 69
[4] Patent: WO2012/117062, 2012, A1, . Location in patent: Page/Page column 29
[5] Journal of Medicinal Chemistry, 1997, vol. 40, # 4, p. 586 - 593
[6] Patent: EP1698635, 2006, A1, . Location in patent: Page/Page column 28
[7] Bioorganic and Medicinal Chemistry Letters, 2008, vol. 18, # 18, p. 5010 - 5014
[8] European Journal of Medicinal Chemistry, 2009, vol. 44, # 3, p. 1024 - 1033
[9] Patent: WO2013/63221, 2013, A1, . Location in patent: Page/Page column 29
[10] Patent: WO2008/129007, 2008, A1, . Location in patent: Page/Page column 35-36
  • 2
  • [ 5348-42-5 ]
  • [ 530-62-1 ]
  • [ 16865-11-5 ]
Reference: [1] Patent: US2005/54628, 2005, A1, . Location in patent: Page/Page column 31
  • 3
  • [ 18672-03-2 ]
  • [ 16865-11-5 ]
YieldReaction ConditionsOperation in experiment
49.5% With sodium nitrite In methanol; chloroform; water Method B
A CuCl2 saturated aqueous solution (15 ml) was diluted to 25 ml with water.
Sodium nitrite (1.035 g, 5 mmole) was dissolved in 5 ml of water and slowly added to the CuCl2 solution.
After two minutes, 2-amino-5,6-dichlorobenzimidazole (0.935 g, 5 mmole) was slowly added in small portions.
The mixture was stirred at room temperature for 1 hr.
Excess CuCl2 solution was added and the mixture was heated on a steam bath for 1 hr.
The aqueous solution was then extracted with ethyl acetate (3*50 ml) and the organic layer was washed with brine, dried with MgSO4, concentrated, and separated on a silica column using 2percent MeOH/CHCl3 to afford 545 mg (49.5percent) of 2,5,6-trichlorobenzimidazole.
1 H NMR, TLC, and MS analysis were identical to the same compound obtained by Method A.
Reference: [1] Journal of Medicinal Chemistry, 1995, vol. 38, # 20, p. 4098 - 4105
[2] Patent: US5248672, 1993, A,
  • 4
  • [ 7440-44-0 ]
  • [ 142356-39-6 ]
  • [ 16865-11-5 ]
Reference: [1] Patent: US5360795, 1994, A,
[2] Patent: US5574058, 1996, A,
  • 5
  • [ 5348-42-5 ]
  • [ 16865-11-5 ]
Reference: [1] Journal of Medicinal Chemistry, 1997, vol. 40, # 4, p. 586 - 593
[2] Journal of Medicinal Chemistry, 1995, vol. 38, # 20, p. 4098 - 4105
[3] Patent: WO2011/23812, 2011, A1,
[4] Patent: WO2012/117062, 2012, A1,
[5] Patent: WO2013/63221, 2013, A1,
[6] Journal of Medicinal Chemistry, 2016, vol. 59, # 15, p. 7188 - 7211
[7] Patent: WO2008/129007, 2008, A1,
[8] Patent: WO2009/134750, 2009, A1,
  • 6
  • [ 142356-39-6 ]
  • [ 16865-11-5 ]
Reference: [1] Synthetic Communications, 1998, vol. 28, # 9, p. 1703 - 1712
  • 7
  • [ 19462-98-7 ]
  • [ 16865-11-5 ]
Reference: [1] Synthetic Communications, 1998, vol. 28, # 9, p. 1703 - 1712
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 16865-11-5 ]

Chlorides

Chemical Structure| 6478-73-5

[ 6478-73-5 ]

5,6-Dichloro-1H-benzo[d]imidazole

Similarity: 0.87

Chemical Structure| 1087737-96-9

[ 1087737-96-9 ]

5,6-Dichlorobenzimidazole Hydrochloride

Similarity: 0.87

Chemical Structure| 4887-82-5

[ 4887-82-5 ]

6-Chloro-1H-benzo[d]imidazole

Similarity: 0.84

Chemical Structure| 4857-06-1

[ 4857-06-1 ]

2-Chloro-1H-benzo[d]imidazole

Similarity: 0.82

Chemical Structure| 18672-03-2

[ 18672-03-2 ]

5,6-Dichloro-1H-benzo[d]imidazol-2-amine

Similarity: 0.78

Related Parent Nucleus of
[ 16865-11-5 ]

Benzimidazoles

Chemical Structure| 6478-73-5

[ 6478-73-5 ]

5,6-Dichloro-1H-benzo[d]imidazole

Similarity: 0.87

Chemical Structure| 1087737-96-9

[ 1087737-96-9 ]

5,6-Dichlorobenzimidazole Hydrochloride

Similarity: 0.87

Chemical Structure| 4887-82-5

[ 4887-82-5 ]

6-Chloro-1H-benzo[d]imidazole

Similarity: 0.84

Chemical Structure| 4857-06-1

[ 4857-06-1 ]

2-Chloro-1H-benzo[d]imidazole

Similarity: 0.82

Chemical Structure| 18672-03-2

[ 18672-03-2 ]

5,6-Dichloro-1H-benzo[d]imidazol-2-amine

Similarity: 0.78